Subscribe To

Price Alert Latest News Economic Calendar News

VTYX / Ventyx Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

ENCINITAS, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that it will report financial results for the fourth quarter and full year 2022 after market close on March 23, 2023. Company management will host a conference call and webcast beginning at 4:30 p.m. ET/ 1:30 p.m. PT that day to discuss the financial results and highlight recent pipeline and business progress. Read More

Demo Live Account See Partner Details

Content Topics

Ventyx

Biosciences

Report

Fourth

Quarter

Full

Year

2022

Financial

Results

Stock

VTYX

Posted: Mar 15 2023, 16:05

Author Name: GlobeNewsWire

VTYX News

By Zacks Investment Research
October 11, 2023

Ventyx (VTYX) Down Despite Positive Ulcerative Colitis Study Data

Ventyx Biosciences (VTYX) announces positive top-line data from a phase II study evaluating its pipeline candidate, VTX002, for treating moderate-to-s

By The Motley Fool
October 10, 2023

Why Shares of Ventyx Biosciences Are Dropping Tuesday

Ventyx is a clinical-stage biotech that focuses on autoimmune disorders. The company's lead therapy candidate is VTX002 to treat moderate-to-severe ul

By Seeking Alpha
August 13, 2023

Ventyx Biosciences, Inc. (VTYX) Q2 2023 Earnings Call Transcript

Start Time: 16:30 January 1, 0000 5:23 PM ET Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q2 2023 Earnings Conference Call August 10, 2023, 16:30 PM ET Com

By The Motley Fool
July 3, 2023

Why Shares of Ventyx Biosciences Rose Monday

Ventyx's shares shot up while insiders were selling. The company is a clinical-stage biotech.

By Seeking Alpha
June 15, 2023

Ventyx: Critical Proof Of Concept Data Later This Year

Ventyx Biosciences, Inc. has a number of interesting assets in mid-stage trials. The company is founded by a successful serial entrepreneur. Phase 2 d

By Seeking Alpha
May 14, 2023

Ventyx Biosciences, Inc. (VTYX) Q1 2023 Earnings Call Transcript

Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Raju Mohan - Founder & Chief Exe

By Pulse2
March 24, 2023

Ventyx Biosciences Stock Flals Over 4%: Details

The stock price of Ventyx Biosciences Inc (NASDAQ: VTYX) fell by over 4% intraday today. This is why.

By Seeking Alpha
March 23, 2023

Ventyx Biosciences, Inc. (VTYX) Q4 2022 Earnings Call Transcript

Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q4 2022 Earnings Conference Call March 24, 2023 4:30 PM ET Company Participants Raju Mohan - Founder & Chief E

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.